The commerce ministry has recommended imposition of anti-dumping duty on Chinese ofloxacin -- a medicine used to treat certain infections -- for five years to guard domestic players from cheap imports from the neighbouring country. Directorate General of Trade Remedies (DGTR) has recommended the duty on imports of 'ofloxacin' and its intermediates from China after concluding in its probe that the product has been exported at dumped prices into India, which impacted the domestic industry. "The authority considers it necessary and recommends imposition of the anti-dumping duty for a period of 5 years," the directorate has said in a notification. Ofloxacin is used to treat certain infections including bronchitis, pneumonia and infection of skin, bladder, urinary tract and prostate. DGTR had conducted the probe following a complaint from Aarti Drugs Ltd about the dumping and initiation of the investigation. The directorate works under the ministry. The recommended duty ranges between
India's Make in India and Atmanirbhar initiatives aim to favour domestic manufacturing and discourage imports, the European Union said
Both countries have made two joint submissions at the WTO as co-sponsors in the past two months
Business Standard brings you the top headlines at this hour
Issues were raised about India's-policy on tyres, import curbs on ACs, quality norms for copier paper and caustic soda, GM-free certification for imported food items, among other things
The total disbursement during 2020 was $48.7 billion, which translates to India getting 4 per cent of the disbursements
The govt is likely to introduce the Development of Enterprise and Service Hubs (DESH) Bill in the upcoming monsoon session of Parliament. How will it overhaul the ecosystem of special economic zones?
The Bill shall propose the re-introduction of certain direct tax benefits, under which units set up in these development hubs shall attract a 15 per cent corporate tax until 2032
India's failure to become a major trading nation has made it treat international negotiations as an irritant
According to the minister, India has a number of Covid vaccines and can help other developing countries to make vaccines
The rupee ended the day at 77.98 to a dollar against a close of 78.07 on Friday
Here are the top BS Opinion articles of the day
The current practice of not imposing Customs duties on electronic transmission will continue till the next ministerial conference (MC13) to be held towards the end of December 2023
WTO experience highlights India's less-than-coherent approach towards trade
Outcomes for India were mixed
Piyush Goyal said perhaps this was the first ministerial where India set the agenda. "We were on the front foot. We were telling other countries what needs to be done"
Serum Institute says while patent waivers for Covid-19 vaccines are 'encouraging', demand for vaccines today is declining
The four-day meeting was extended by a day
The prospect of ending the moratorium, which has exempted data flows from cross-border tariffs since 1998, had raised major concerns among businesse
Negotiations on fisheries are going on and members are quite close to a deal with carve-outs for India and other developing countries, said an Indian trade negotiator on condition of anonymity